DSCSA Standards for the Interoperable Exchange of Information for Tracing of Certain Human, Finished, Prescription Drugs: How to Exchange Product Tracing Information; Availability

Please see the attached comment letter on behalf of American Pharmacists Association. Thank you.

The American Pharmacists Association (APhA) is pleased to submit comments on the revised draft guidance entitled "Drug Supply Chain Security Act Standards for the Interoperable Exchange of Information for Tracing of Certain Human, Finished, Prescription Drugs." APhA is the only organization advancing the entire pharmacy profession. Our expert staff and strong volunteer leadership, including many experienced pharmacists, allow us to deliver vital leadership to help pharmacists, pharmaceutical scientists, student pharmacists, and pharmacy technicians find success and satisfaction in their work while advocating for changes that benefit them, their patients, and their communities. APhA strongly supports the purpose and goals of the Drug Supply Chain Security Act (DSCSA) to enhance the safety and security of the pharmaceutical distribution supply chain. APhA also appreciates FDA's efforts in developing guidance, standards, and other information to assist pharmacists and pharmacies in complying with DSCSA's requirements. Read the attached .PDF for our full comments. APhA appreciates FDA's ongoing efforts in developing guidance, standards, and other information to assist pharmacists and pharmacies in complying with DSCSA's requirements. We look forward to continuing to support FDA's efforts and working to improve the safety and security of the drug supply chain.